Patient characteristics in the entire cohort and groups with or without candida esophagitis.

CE, candida esophagitis; HIV, human immunodeficiency virus; IQR, interquartile range; HAART, highly active anti-retroviral therapy; HBV, hepatitis B virus; HCV, hepatitis C virus; NSAIDs, non-steroidal anti-inflammatory drugs; H2RA, H2-receptor antagonist.
Data are presented as number (%) or mean ±SD.
*p values for the comparison between patients with CE and those without CE.
Patient characteristics in the entire cohort and groups with or without candida esophagitis.